Skip to main content
FinSpry Logo
FinSpry
OLMA logo
OLMA
(NASDAQ)
Olema Pharmaceuticals, Inc.
$15.06-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Olema Pharmaceuticals, Inc. (OLMA) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Olema Pharmaceuticals, Inc. stock.

Analyst Consensus Rating

Investment consensus from 9 professional research analysts

Consensus Rating

Strong Buy
Based on 9 unique analysts
Medium Confidence∞:1 Buy/Sell

Average Price Target

$44.50
↑ 195.48% Upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest OLMA Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Kalpit Patel
Wolfe Research
HoldInitiates
-
Dennis Ding
Jefferies
Strong BuyInitiates
$43.00 → $40.00
Richard Law
Goldman Sachs
Strong BuyMaintains
$38.00 → $27.00
Anupam Rama
JP Morgan
BuyMaintains
$55.00 → $58.00
Brad Canino
Guggenheim
Strong BuyMaintains
$40.00 → $38.00
Yigal Nochomovitz
Citi
Strong BuyMaintains
$60.00 → $62.00
Emily Bodnar
HC Wainwright
Strong BuyMaintains
$36.00 → $38.00
Laura Prendergast
Stifel
Strong BuyInitiates
$48.00
Michael Yee
UBS
Strong BuyInitiates
$45.00

Frequently Asked Questions

What is the analyst consensus rating for OLMA?

The analyst consensus rating for OLMA is "Strong Buy" based on 9 analyst recommendations.

What is the average price target for OLMA?

The average 12-month price target for OLMA is $44.50, representing an upside of 195.5% from the current price of $15.06.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.